Shared Decision Making Tool for Kidney Transplant Candidates

Recruiting in Palo Alto (17 mi)

+1 other location

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Hennepin Healthcare Research Institute

Disqualifiers: Non-English, Under 18, opt out, others

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial aims to help kidney transplant candidates make better decisions by using an online tool that educates them about donor options, facilitates discussions with doctors, and gathers their preferences.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on decision-making tools rather than medication changes.

What data supports the effectiveness of the treatment 'Shared Decision Making Tool for Kidney Transplant Candidates'?

Research shows that shared decision-making, where patients and doctors work together to make healthcare decisions, improves outcomes in chronic kidney disease and other conditions. This approach helps patients understand their treatment options better and can lead to improved survival and slower disease progression. ^{1 2 3 4 5}

Is shared decision making for kidney transplant candidates safe?

The research does not provide specific safety data for shared decision making in kidney transplant candidates, but it emphasizes the importance of informed consent and patient education to ensure safe and effective decision-making. ^{1 2 5 6 7}

How is the Shared Decision Making Tool for Kidney Transplant Candidates treatment different from other treatments?

This treatment is unique because it focuses on shared decision making, a collaborative process where patients and healthcare providers work together to make informed decisions about kidney transplants. Unlike traditional approaches, it emphasizes patient education and empowerment, helping patients understand their options and align treatment with their personal values and preferences. ^{1 2 3 5 8}

Research Team

Eligibility Criteria

This trial is for English-speaking adults over 18 who have been on the kidney transplant waiting list for more than three months. It's not suitable for those under 18, non-English speakers, patients who opt out of research, or anyone unable to give informed consent.

Inclusion Criteria

English-speaking

I have been on the transplant list for more than 3 months.

I am 18 years old or older.

Exclusion Criteria

Non-English speaking

I am under 18 years old.

I choose not to participate in research studies.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants review the Donor Plan Donor Choice tool and discuss a Kidney Offer Plan with a transplant provider

Up to 2 months

Multiple visits (in-person and virtual)

Follow-up

Participants are monitored for knowledge, decisional conflict, distress, and shared decision making outcomes

Up to 2 months

Treatment Details

Interventions

• Kidney Offer Shared Decision Making (Behavioral Intervention)

Trial Overview The study tests a tool called 'Donor Plan Donor Choice' designed to help kidney transplant candidates make decisions with their doctors about organ offers. Participants will use an online educational tool and discuss donor types with providers.

Participant Groups

Group I: Shared Decision Making Intervention Experimental Treatment 1 Intervention

Receives the Shared Decision Making Intervention

Group II: Usual Care Active Control 1 Intervention

Receives Usual Care, eg. usual patient education and counseling for kidney transplant candidates.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Hennepin Healthcare Minneapolis, MN

Mayo Clinic Rochester, MN

Who Is Running the Clinical Trial?

Hennepin Healthcare Research Institute

Lead Sponsor

Trials

94

Patients Recruited

77,100+

Mayo Clinic

Collaborator

Trials

3427

Patients Recruited

3,221,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials

2513

Patients Recruited

4,366,000+

References

1. United States pubmed.ncbi.nlm.nih.gov

Opportunities for shared decision making in kidney transplantation. [2023]

2. New Zealand pubmed.ncbi.nlm.nih.gov

Supporting Shared Decision-Making and Home Dialysis in End-Stage Kidney Disease. [2023]

3. Korea (South) pubmed.ncbi.nlm.nih.gov

Evaluating a shared decision-making intervention regarding dialysis modality: development and validation of self-assessment items for patients with chronic kidney disease. [2022]

4. England pubmed.ncbi.nlm.nih.gov

Shared decision-making in advanced kidney disease: a scoping review. [2022]

5. United States pubmed.ncbi.nlm.nih.gov

Choosing wisely and beyond: shared decision making and chronic kidney disease. [2022]

6. England pubmed.ncbi.nlm.nih.gov

The 3-Step Model of informed consent for living kidney donation: a proposal on behalf of the DESCaRTES Working Group of the European Renal Association. [2023]

7. Denmark pubmed.ncbi.nlm.nih.gov

Cultural competency of a mobile, customized patient education tool for improving potential kidney transplant recipients' knowledge and decision-making. [2022]

8. England pubmed.ncbi.nlm.nih.gov

Healthcare professional education in shared decision making in the context of chronic kidney disease: a scoping review. [2023]